Additional file 1: Appendix 1. of 
                     Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)âstudy protocol for a 2Ă2 factorial randomized trial

Campbell, David; Tonelli, Marcello; Hemmelgarn, Brenda; Mitchell, Chad; Tsuyuki, Ross; Ivers, Noah; Campbell, Tavis; Pannu, Raj; Verkerke, Eric; Klarenbach, Scott; King-Shier, Kathryn; Faris, Peter; Exner, Derek; Chaubey, Vikas; Manns, Braden

doi:10.6084/m9.figshare.c.3597653_D1.v1

13012_2016_491_MOESM1_ESM.docx (131.25 kB)

Additional file 1: Appendix 1. of Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)âstudy protocol for a 2Ă2 factorial randomized trial

journal contribution

posted on 2016-09-26, 05:00 authored by David Campbell, Marcello Tonelli, Brenda Hemmelgarn, Chad Mitchell, Ross Tsuyuki, Noah Ivers, Tavis Campbell, Raj Pannu, Eric Verkerke, Scott Klarenbach, Kathryn King-Shier, Peter Faris, Derek Exner, Vikas Chaubey, Braden Manns

Medications included in copayment elimination intervention. Appendix 2. ICD10-CA definitions of the components of our primary clinical endpoint. Appendix 3. Alberta Kidney Disease Network Administrative Database. Appendix 4. Informed consent form. (DOCX 131 kb)

Funding

Alberta Innovates - Health Solutions

History

Usage metrics

Keywords

Randomized clinical trial Chronic disease Cost Education Drug insurance

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1: Appendix 1. of Assessing outcomes of enhanced chronic disease care through patient education and a value-based formulary study (ACCESS)âstudy protocol for a 2Ă2 factorial randomized trial